Who
Renee Aguiar-Lucander
Director
Company insider
Files Form 4 as: Director, AC Immune SA; Director, Egalet.
In numbers
- Trades disclosed
- 9
- Buys
- 1
- Sells
- 0
- Bought
- $1000K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 11 Feb 2014
- Last trade
- 11 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 15 Jun 2026 | ACIU AC Immune SABiotechnology | SEC FORM 4 Code A | —16,568 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | ACIU AC Immune SAoption or derivative · Biotechnology | SEC FORM 4 Code A | —38,889 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | ACIU AC Immune SAoption or derivative · Biotechnology | SEC FORM 4 Code A | —38,889 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | ACIU AC Immune SABiotechnology | SEC FORM 4 Code A | —16,568 at $0.00 | filing |
| 11 Feb 2014filed 12 Feb 2014 | Egalet | SEC FORM 4 Code X | —60,000 at $0.00 | filing |
| 11 Feb 2014filed 12 Feb 2014 | Egalet | SEC FORM 4 Code C | $1.0M171,241 at $6.00 | filing |
| 11 Feb 2014filed 12 Feb 2014 | Egalet | SEC FORM 4 Bought | $1000K83,333 at $12.00 | filing |
| 11 Feb 2014filed 12 Feb 2014 | Egaletoption or derivative | SEC FORM 4 Code X | —60,000 at $0.00 | filing |
| 11 Feb 2014filed 12 Feb 2014 | Egaletoption or derivative | SEC FORM 4 Code C | — | filing |
News
No headline names them, or the companies they trade most, lately.